Aquabounty Technologies

Penny Stocks Biotech Stocks Healthcare Stocks

$0.90

+0.05 (+5.70%)

As of Nov 14, 2:53 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 38%

Sell 5 63%

Price Target

Analyst Price Target +2,243.3% upside

Low Target $14.27

Average Target $21.09

High Target $34.90

Current Price $0.90

Current
$0.90

Target
$21.09

$14.27 $21.09 avg $34.90

Scenario Analysis

Bear Case

$14.27

1,485.6%

Low target

Base Case

$21.09

+2,243.3%

Avg target

Bull Case

$34.90

+3,777.8%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$1.64

-45.1% from high

52-Week Low

$0.77

+16.2% from low

Target vs 52W High

$21.09

+1,186.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%